FDA Approves Rukabia for HIV Treatment
Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation My Account Contact The U.S. Food and Drug Administration (FDA) on December 22, 2022 announced the approval of a new HIV drug called Rukobia (fostemsavir) for adults...FDA Approval for Cancer Treatment Aid
Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation My Account Contact The Food and Drug Administration (FDA) on 12 December 2022 announced the approval of Agilent’s Resolution CTDX FIRST, a new in vitro diagnostic...FDA Accelerated Approval for Alzheimer’s Disease Treatment
Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation My Account Contact The US Food and Drug Administration (FDA) announced on 06 January, 2023 that it had granted accelerated approval for the Alzheimer’s disease...Regulatory Documentation for National and Global Market Access
With a solid base of technical documentation, our regulatory specialists will prepare a regulatory submission that is organized, well written, complete, and meets the regulatory requirements of the agency that will evaluate the product.